Synthesis and validation of a novel cyclic growth hormone
Project Title: „Synthesis and validation of a novel cyclic growth hormone”
Funding: European Regional Development Fund (ERDF)
Project No.: 2014/0012/2DP/18.104.22.168.0/14/APIA/VIAA/038
Period: 13 months (August 1, 2014 – August 31, 2015)
Project costs: EUR 160 036.00
Principle Investigator: Dr. A.Leončiks
The general aim of the project is the development of a new modified human growth hormone (somatotropin) for the treatment of hormone-deficiency diseases.
The specific aim of the project is the synthesis of cyclic somatotropin and validation of its biological activity.